Transcranial Direct Current Stimulation for Post-stroke Fatigue
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University
About this trial
The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.
Eligibility criteria
Qualifiers
Male or female patients aged >18 years
Greater than 3 months from first hemorrhagic or ischemic stroke (subacute to chronic), confirmed through neuroimaging (CT or MRI).
Fatigue severity score average >4 (severe fatigue)
Willingness to remain stable on pharmacologic therapy through the duration of the study.
Disqualifiers
Metal in the head (except mouth) or implanted cranial or thoracic devices (i.e. pacemaker, DBS stimulator)
History of seizure
History of moderate to severe traumatic brain injury
A score of 10 or more on the PHQ-9 or GAD-7 scale, suggestive of moderate to severe depression/anxiety.
Trial design
Treatments tested in this trial
- Real Soterix Mini-CT tDCS stimulator
- Sham Soterix Mini-CT tDCS stimulator
Treatment groups
24 Participants
are divided into 2 treatment groupsSponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
American Heart Association
Collaborator
Source ClinicalTrials.gov